Trends in mortality after XXXX diagnosis: A nationwide cohort study over 45 years of follow-up in Sweden by country of birth.

@entity1 @entity0 @entity5 @entity694 @entity204
BACKGROUND: Survival has steadily improved for major @entity5 types in most parts of the world. We compared all-cause mortality between foreign-born and Sweden-born residents of Sweden who were diagnosed with @entity694 , lung, stomach, prostate, breast, cervix, and all site. METHODS: We used Swedish national vital status and health registers to follow a cohort of 1,556,108 @entity1 45 years of age and older diagnosed with @entity5 between 1961 and 2009 in Sweden. Among them, 109,915 were born abroad. We estimated hazard ratios (HR) and 95% confidence interval (CI) using multivariable Cox proportional hazard models. RESULTS: We identified 604,035 and 540,138 @entity204 among @entity1 and @entity1 , respectively. Among them 33,595 @entity1 and 34,174 @entity1 were born abroad. At the time of diagnosis, @entity1 born abroad were on average 4 years younger than @entity1 born in Sweden. All-cause mortality was generally lower in the former than in the latter group of @entity1 before 1990 but higher after 2000. The mortality trend was similar for prostate and @entity0 . CONCLUSIONS: Whilst national policy in Sweden aims at achieving equal access to health care, the mortality trend observed among @entity5 @entity1 born in Sweden was different from that observed among @entity1 born elsewhere. Mortality after diagnosis of major types of @entity5 has worsened among foreign-born after the year 2000. The possible determinants of disparities need be identified and investigated.
